Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation

  • Commun Biol. 2020 Mar 17;3(1):128. doi: 10.1038/s42003-020-0845-0.
Nikolaos Patsoukis  1  2 Jonathan S Duke-Cohan  3 Apoorvi Chaudhri  3  4 Halil-Ibrahim Aksoylar  1  2 Qi Wang  1  2 Asia Council  1  2 Anders Berg  5  6 Gordon J Freeman  3 Vassiliki A Boussiotis  7  8
Affiliations
  • 1. Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA.
  • 2. Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
  • 3. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02215, USA.
  • 4. MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.
  • 5. Department of Pathology Beth Israel Deaconess Cancer Center, Harvard Medical School, Boston, MA, 02215, USA.
  • 6. Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • 7. Division of Hematology-Oncology Beth Israel Deaconess Medical Center, Boston, MA, 02215, USA. [email protected].
  • 8. Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. [email protected].
Abstract

Programmed cell death-1 (PD-1) inhibits T cell responses. This function relies on interaction with SHP-2. PD-1 has one immunoreceptor tyrosine-based inhibitory motif (ITIM) at Y223 and one immunoreceptor tyrosine-based switch motif (ITSM) at Y248. Only ITSM-Y248 is indispensable for PD-1-mediated inhibitory function but how SHP-2 enzymatic activation is mechanistically regulated by one PD-1 phosphotyrosine remains a puzzle. We found that after PD-1 phosphorylation, SHP-2 can bridge phosphorylated ITSM-Y248 residues on two PD-1 molecules via its amino terminal (N)-SH2 and carboxyterminal (C)-SH2 domains forming a PD-1: PD-1 dimer in live cells. The biophysical ability of SHP-2 to interact with two ITSM-pY248 residues was documented by isothermal titration calorimetry. SHP-2 interaction with two ITSM-pY248 phosphopeptides induced robust enzymatic activation. Our results unravel a mechanism of PD-1: SHP-2 interaction that depends only on ITSM-Y248 and explain how a single docking site within the PD-1 cytoplasmic tail can activate SHP-2 and PD-1-mediated inhibitory function.

Products